Erlotinib Completed Phase 1 / 2 Trials for Stage III Squamous Cell Carcinoma of the Oropharynx / Stage IVB Squamous Cell Carcinoma of the Larynx / Stage IVB Squamous Cell Carcinoma of the Oropharynx / Stage IIIb Non-small Cell Lung Cancer / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Stage III Squamous Cell Carcinoma of the Larynx / Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IV Non-Small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IVA Squamous Cell Carcinoma of the Oropharynx / Recurrent Squamous Cell Carcinoma of the Oropharynx / Stage IVC Squamous Cell Carcinoma of the Oropharynx / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage III Squamous Cell Carcinoma of the Nasopharynx / Recurrent Squamous Cell Carcinoma of the Larynx / Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Ovarian Epithelial Cancer / Non-Small Cell Lung Cancer Recurrent / Stage IIIA Ovarian Epithelial Cancer / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Stage IIIB Ovarian Epithelial Cancer / Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IVA Squamous Cell Carcinoma of the Larynx / Stage IIIC Ovarian Epithelial Cancer / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Stage III Squamous Cell Carcinoma of the Hypopharynx / Stage IV Squamous Cell Carcinoma of the Hypopharynx / Stage IV Ovarian Epithelial Cancer / Stage IVC Squamous Cell Carcinoma of the Larynx Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00088959Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT01839955Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer